US at a glance
- Population
- 341.8 million 2025
- Life expectancy at birth
- 78.9 years, 2024
- People aged 65 and over
- 18.4 % of people, 2025
- Health spending per person
- 13,473 US$ per person, 2023
- Doctors
- 3.68 per 1,000 people, 2022
US Breast Pumps Market Industry Trends and Forecast to 2034: Segmented by (Product, Use, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
US · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
US (this report) at $1.49 Bn.
Canada at 8.2% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$1.03 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.41 Bn | — | — |
| 2025 (base) | $1.49 Bn | +$84.4 Mn | — |
| 2026 (forecast) | $1.58 Bn | +$89.4 Mn | +6% |
| 2027 (forecast) | $1.67 Bn | +$94.8 Mn | +12.4% |
| 2028 (forecast) | $1.78 Bn | +$100.5 Mn | +19.1% |
| 2029 (forecast) | $1.88 Bn | +$106.5 Mn | +26.2% |
| 2030 (forecast) | $1.99 Bn | +$112.9 Mn | +33.8% |
| 2031 (forecast) | $2.11 Bn | +$119.7 Mn | +41.9% |
| 2032 (forecast) | $2.24 Bn | +$126.9 Mn | +50.4% |
| 2033 (forecast) | $2.38 Bn | +$134.5 Mn | +59.4% |
| 2034 (forecast) | $2.52 Bn | +$142.5 Mn | +68.9% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US (this report)
$1.49 Bn
Canada
$251.7 Mn
China
$257.7 Mn
Japan
$185.9 Mn
Germany
$125.5 Mn
France
$91.2 Mn
Brazil
$89.2 Mn
UK
$74.1 Mn
Ecuador
$74.3 Mn
Italy
$70.4 Mn
Spain
$68.0 Mn
India
$61.9 Mn
Saudi Arabia
$56.8 Mn
Mexico
$46.8 Mn
Australia
$39.0 Mn
New Zealand
$33.8 Mn
Russia
$33.0 Mn
South Africa
$25.7 Mn
UAE
$14.7 Mn
Egypt
$11.0 Mn
Philippines
$7.5 Mn
Malaysia
$5.8 Mn
Hong Kong
$5.3 Mn
Singapore
$4.3 Mn
Thailand
$4.1 Mn
Kenya
$2.1 Mn
| Market size, 2025 | $1.49 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $2.52 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 6.0% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, use and end user (see all) |
| Key players | Medela, Elvie (Chiaro), Willow Innovations, Philips Avent, Lansinoh and 1 more (see all) |
| Regulator in the US | FDASource: US Food and Drug Administration. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Breast pumps help mothers express breast milk, with manual, electric and wearable models for home and hospital use.
Key segments of the breast Pumps market include product (Wearable Pumps, Electric Pumps and Manual Pumps) and use (Personal Use, Hospital Use and Rental).
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the breast Pumps market. New products designed around women's biology and digital care are improving access.
Femtech, personalised care and new treatments for under-served conditions open strong growth for the breast Pumps market, especially as employers and payers add women's health benefits.
Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the breast Pumps market.
The breast Pumps market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA).[1] Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).[2]
[1] US Food and Drug Administration. Checked 14 Nov 2026.
[2] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how breast Pumps products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.
What doctors and scientists are doing in Breast Pumps right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
From our blog
Pharmaceuticals · US
Healthcare Services · US
Pharmaceuticals · US
Pharmaceuticals · US
Pharmaceuticals · US
Healthcare Services · US